Informed and vigorous defense of federal investigations and whistleblower lawsuits involving the FCA.
Husch Blackwell has a deep roster of experienced litigators—many of whom are former federal prosecutors—who handle False Claims Act (FCA) investigations and whistleblower litigation.
FCA and qui tam litigation is defined by high stakes and rapid evolution of this Civil War-era law to cover emerging areas, including healthcare and cybersecurity. Our FCA teams bring a wealth of experience and thorough understanding of the FCA and its qui tam provision to each matter, and routinely guide clients through disputes at all phases, from initial setting up compliance programs, and conducting internal investigations, to interfacing with the Department of Justice during its investigation, to responding to a civil investigative demand, to developing winning trial strategies.
In recent years, most False Claims Act litigation has featured healthcare industry defendants, and our FCA litigation team works closely with our nationally ranked Healthcare Regulatory group to resolve disputes that involve the industry. More recently, the Department of Justice has expanded its application of the FCA to cover alleged misrepresentations in connection with the cybersecurity requirements in certain federal government contracts, as well as pressing forward with novel “reverse” FCA investigations and lawsuits. In response our False Claim Act attorneys collaborate with Husch Blackwell’s Government Contracts and Cybersecurity teams to develop robust defenses for clients embroiled in these emerging areas of FCA litigation.
Across all industries and situations, our deep knowledge of the FCA and how the Department of Justice pursues FCA cases is a core team strength that enables us to position clients for favorable outcomes.